3D Global Biotech Inc.
3D Global Biotech Inc. develops medical materials for human body reconstruction in China. It uses cell culture systems, 3D printing technology, and bio-inks hydrogel as the basis to develop and produce customized autologous cell-based medical products. The company develops human tissue and organ reconstruction platforms; develops customized and personalized medical equipment; and conducts profess… Read more
Market Cap & Net Worth: 3D Global Biotech Inc. (6808)
3D Global Biotech Inc. (TWO:6808) has a market capitalization of $83.30 Million (NT$2.76 Billion) as of March 18, 2026. Listed on the TWO stock exchange, this Taiwan-based company holds position #20633 globally and #1090 in its home market, demonstrating a -7.97% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying 3D Global Biotech Inc.'s stock price NT$35.80 by its total outstanding shares 76982000 (76.98 Million).
3D Global Biotech Inc. Market Cap History: 2026 to 2026
3D Global Biotech Inc.'s market capitalization history from 2026 to 2026. Data shows growth from $83.30 Million to $83.30 Million (0.00% CAGR).
3D Global Biotech Inc. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how 3D Global Biotech Inc.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 6808 by Market Capitalization
Companies near 3D Global Biotech Inc. in the global market cap rankings as of March 18, 2026.
Key companies related to 3D Global Biotech Inc. by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
3D Global Biotech Inc. Historical Marketcap From 2026 to 2026
Between 2026 and today, 3D Global Biotech Inc.'s market cap moved from $83.30 Million to $ 83.30 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | NT$83.30 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of 3D Global Biotech Inc. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $83.30 Million USD |
| MoneyControl | $83.30 Million USD |
| MarketWatch | $83.30 Million USD |
| marketcap.company | $83.30 Million USD |
| Reuters | $83.30 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.